[Toward a therapeutic use of cannabinoid CB(2) receptor in atherosclerosis].
Steffens
Sabine
S
Division de Cardiologie, Département de Médecine, Centre hospitalier universitaire, Fondation pour la Recherche Médicale, Genève, Suisse.
Mach
François
F
D018712:Analgesics, Non-Narcotic / Q000627:therapeutic use; D050197:Atherosclerosis / Q000188:drug therapy*; D002186:Cannabinoids / Q000627:therapeutic use*; D013759:Dronabinol / Q000627:therapeutic use*; D006801:Humans; D011619:Psychotropic Drugs / Q000627:therapeutic use*; D043885:Receptor, Cannabinoid, CB2 / Q000502:physiology*
D018712:Analgesics, Non-Narcotic; D002186:Cannabinoids; D011619:Psychotropic Drugs; D043885:Receptor, Cannabinoid, CB2; D013759:Dronabinol